/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-986177/JNJ-70033093, a direct, reversible, small molecule Factor XIa inhibitor in healthy volunteers
Event: ESC Congress 2020
Topic: Anticoagulants
Session: Antithrombotic Therapy Update
Single-dose pharmacokinetics of BMS-986177/JNJ-70033093 in participants with mild or moderate hepatic impairment compared to healthy participants
Event: ESC Congress 2020
Topic: Anticoagulants
Session: Pharmacology and Pharmacotherapy ePosters
